HVII
NASDAQ · N/A
Hennessy Capital Investment
$10.46
+0.01 (+0.10%)
Open$10.44
Previous Close$10.45
Day High$10.46
Day Low$10.44
52W High$10.99
52W Low$10.13
Volume—
Avg Volume21.2K
Market Cap272.20M
P/E Ratio83.88
EPS$0.13
SectorN/A
Analyst Ratings
Strong Buy
7 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 57.07M | 54.12M | 51.76M |
| Net Income | 2.53M | 2.55M | 2.01M |
| Profit Margin | 4.4% | 4.7% | 3.9% |
| EBITDA | 3.87M | 3.96M | 3.96M |
| Free Cash Flow | 3.63M | 3.39M | 2.49M |
| Rev Growth | -2.1% | +4.6% | +4.8% |
| Debt/Equity | 0.67 | 0.71 | 0.62 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.33 | +0.96% | — | 3.76B |
| PICS | Pics Nv | $11.06 | -1.60% | 6.4 | 1.43B |
| DMII | Drugs Made In America Acquis | $10.09 | +0.20% | 74.9 | 642.73M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.70 | +0.28% | 35.3 | 335.10M |
| CEPF | Cantor Equity Partners-Cl A | $10.40 | -0.10% | 57.7 | 594.36M |